Ligand Pharmaceuticals Inc stock is traded at $299.00, with a volume of 247,825. It is down -5.42% in the last 24 hours and down -2.53% over the past month. Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Previous Close:
$316.13
Open:
$316.57
24h Volume:
247,825
Relative Volume:
0.99
Market Cap:
$5.98B
Revenue:
$274.48M
Net Income/Loss:
$153.56M
P/E Ratio:
40.54
EPS:
$7.38
Net Cash Flow:
$114.06M
1W Performance:
-5.78%
1M Performance:
-2.53%
6M Performance:
+28.71%
1Y Performance:
+57.05%
1-Day Range:
$297.63$318.98
1-Week Range:
$297.63$325.96
52-Week Range:
$175.89$326.63
Ligand Pharmaceuticals Inc Stock (LGND) Company Profile
Name
Ligand Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
858-550-7500Address
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS